drugs other than benzodiazepines in the two preceding weeks, and the estimations were carried out in ignorance of the subjects' clinical condition. We detected DMT in the urine of all subjects, both patients and controls. The level of excretion ranged from 63 to 4500 ng per 24 hours, and the mean levels were much higher for psychotic patients than for neurotic and normal individuals ( in patients who are psychiatrically ill (Farmer 1975 , Foster et a!. 1974 In addition, some abnormal reactions seem to be caused by family stress, and early psychiatric intervention at critical stages, e.g. when a kidney donor is being chosen, may prevent these.
Treatment with tricyclic antidepressants may occasionally seem necessary, but the particular hazards of using these drugs in patients on dialysis have not been adequately explored. Hemodialysis might be expected to affect their disposal and thus to alter their concentrations in the plasma.
In physically healthy people the steady-state plasma concentration of tricyclic antidepressants varies greatly between individuals (Hammer et a!. 1969 ) and is normally reached within about a week (Asberg 1973) . On a once daily dose of amitriptyline, in a particular individual, it varies by not more than 30% (Braithwaite et al. 1974 ).
There seems to be a relationship between the efficacy of the drug and its plasma concentration, although its precise nature remains controversial (Asberg et al. 1971 , Burrows et al. 1972 , Braithwaite et al. 1972 , Burrows et al. 1974 . In addition to a lower limit of about 50 ng/ml, for nortryptyline, for example, there may be a therapeutic upper limit. Asberg et al. (1971) reported a diminution in efficacy when nortryptyline concentrations exceeded 140 ng/ml, whereas toxicity presumably continues to increase.
Most of the active drug is bound to plasma proteins (Borga et al. 1969) . Sixty percent of amitriptyline is excreted by the kidneys, mainly as glucuronides of 10-hydroxy didesmethyl derivatives (Braithwaite & Widdop 1971 , Diamond 1965 . In patients in end-stage renal failure breakdown products accumulate and are disposed of during dialysis.
In several severely depressed patients on hmmodialysis recovery followed on a surprisingly low dosage of tricyclic antidepressants. To ascertain whether the breakdown of active drug had slowed down because of the accumulation of breakdown products, resulting in plasma concentrations of active drug which were higher than would be expected in normal patients on such doses, serial measurements were obtained in 3 patients on hospital dialysis, all suffering from life-threatening depressive illnesses (Table 1) Optimal concentration of nortriptyline 50-140 ng/ml (Asberg) Plasma nortriptyline and amitriptyline were determined by gas chromatography by the method described by Braithwaite & Widdop (1971) . Test-retest reliabilitv was satisfactory.
Erratic variations in plasma concentration occurred during 8 hours of dialysis. These were often greater than those occurring in normal people in 24 hours following a single dose. Larger falls in plasma concentration tended to coincide with greater weight loss during dialysis. Considerable variation also occurred in plasma levels from day to day.
The plasma concentrations were much higher than expected in normal patients on such doses and were similar to, or in excess of, those reported by our own and other laboratories in physically normal patients taking much higher doses.
In Case 1, although pre-dialysis concentrations exceeded the recommended upper limit and postdialysis concentrations were sometimes low, pre-dialysis concentrations were fairly steady from day to day. He made a good recovery and complained of no side-effects. In Case 2, concentrations varied markedly between dialyses. She improved but her mental state remained brittle and she complained of mild side-effects. 
